Study of Cryotherapy for Renal Tumors

Renal Tumors Clinical Trial

Official title:

Study of Cryotherapy for Renal Tumors

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT00858975
• Other study ID #: 200709063R
• Status: Withdrawn
• Phase: N/A
• First received: March 9, 2009
• Last updated: August 12, 2013
• Start date: October 2007
• Est. completion date: December 2012

Study information

• Verified date: December 2012
• Source: National Taiwan University Hospital
• Contact: n/a
• Is FDA regulated: No
• Health authority: Taiwan: Department of Health
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to study the change of tumor size and serum cytokine in the patients who received cryotherapy for the renal tumors.

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. completion date: December 2012
• Est. primary completion date: December 2012
• Accepts healthy volunteers: No
• Gender: Both
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• The patients who have renal tumor less than 7 cm and receive cryotherapy

Exclusion Criteria:

• The tumor size is larger than 7 cm

• The patients do not approve the surgery

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Kidney Neoplasms
• Renal Tumors

Intervention

Procedure:
• cryotherapy
Placing 4-6 cryotherapy probes into the renal tumors and conducting two cycles of freezing and thawing

Locations

Country	Name	City	State
Taiwan	National Taiwan University Hospital	Taipei

Sponsors (1)

Lead Sponsor	Collaborator
National Taiwan University Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Tumor size		3 months	No